New polymorphic form of doxazosin mesylate (form II)

A new crystalline and anhydrous form of doxazosin mesylate is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 10.68 DEG, 23.45 DEG, 14.45 DEG, 23.82 DEG, 17.37 DEG, 24.30 DEG. Owing to its...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MORSDORF, JOHANN PETER, GRAFE, INGOMAR
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	MORSDORF, JOHANN PETER GRAFE, INGOMAR
description	A new crystalline and anhydrous form of doxazosin mesylate is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 10.68 DEG, 23.45 DEG, 14.45 DEG, 23.82 DEG, 17.37 DEG, 24.30 DEG. Owing to its crystalline properties, the new form of doxazosin mesylate according to the invention has surprising advantages both with regard to its synthesis and for pharmaceutical processing into solid dosage forms. A process for preparing the new form of doxazosin mesylate and medicaments containing the new form of doxazosin mesylate are also described.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW466239BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW466239BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW466239BB3</originalsourceid><addsrcrecordid>eNrjZDDxSy1XKMjPqczNLyrIyExWSMsvylXIT1NIya9IrMovzsxTyE0trsxJLElV0ADLeXpq8jCwpiXmFKfyQmluBnk31xBnD93Ugvz41OKCxOTUvNSS-JBwEzMzI2NLJydjwioAZjYr0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New polymorphic form of doxazosin mesylate (form II)</title><source>esp@cenet</source><creator>MORSDORF, JOHANN PETER ; GRAFE, INGOMAR</creator><creatorcontrib>MORSDORF, JOHANN PETER ; GRAFE, INGOMAR</creatorcontrib><description>A new crystalline and anhydrous form of doxazosin mesylate is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 10.68 DEG, 23.45 DEG, 14.45 DEG, 23.82 DEG, 17.37 DEG, 24.30 DEG. Owing to its crystalline properties, the new form of doxazosin mesylate according to the invention has surprising advantages both with regard to its synthesis and for pharmaceutical processing into solid dosage forms. A process for preparing the new form of doxazosin mesylate and medicaments containing the new form of doxazosin mesylate are also described.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011201&DB=EPODOC&CC=TW&NR=466239B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011201&DB=EPODOC&CC=TW&NR=466239B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MORSDORF, JOHANN PETER</creatorcontrib><creatorcontrib>GRAFE, INGOMAR</creatorcontrib><title>New polymorphic form of doxazosin mesylate (form II)</title><description>A new crystalline and anhydrous form of doxazosin mesylate is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 10.68 DEG, 23.45 DEG, 14.45 DEG, 23.82 DEG, 17.37 DEG, 24.30 DEG. Owing to its crystalline properties, the new form of doxazosin mesylate according to the invention has surprising advantages both with regard to its synthesis and for pharmaceutical processing into solid dosage forms. A process for preparing the new form of doxazosin mesylate and medicaments containing the new form of doxazosin mesylate are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDxSy1XKMjPqczNLyrIyExWSMsvylXIT1NIya9IrMovzsxTyE0trsxJLElV0ADLeXpq8jCwpiXmFKfyQmluBnk31xBnD93Ugvz41OKCxOTUvNSS-JBwEzMzI2NLJydjwioAZjYr0A</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>MORSDORF, JOHANN PETER</creator><creator>GRAFE, INGOMAR</creator><scope>EVB</scope></search><sort><creationdate>20011201</creationdate><title>New polymorphic form of doxazosin mesylate (form II)</title><author>MORSDORF, JOHANN PETER ; GRAFE, INGOMAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW466239BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MORSDORF, JOHANN PETER</creatorcontrib><creatorcontrib>GRAFE, INGOMAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MORSDORF, JOHANN PETER</au><au>GRAFE, INGOMAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New polymorphic form of doxazosin mesylate (form II)</title><date>2001-12-01</date><risdate>2001</risdate><abstract>A new crystalline and anhydrous form of doxazosin mesylate is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 10.68 DEG, 23.45 DEG, 14.45 DEG, 23.82 DEG, 17.37 DEG, 24.30 DEG. Owing to its crystalline properties, the new form of doxazosin mesylate according to the invention has surprising advantages both with regard to its synthesis and for pharmaceutical processing into solid dosage forms. A process for preparing the new form of doxazosin mesylate and medicaments containing the new form of doxazosin mesylate are also described.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_TW466239BB
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	New polymorphic form of doxazosin mesylate (form II)
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A27%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MORSDORF,%20JOHANN%20PETER&rft.date=2001-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW466239BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true